Loading Studies...
Keyword Search
Browse All Studies
Login / Create Account
Login
Create Account
Sponsors/Funders
How to Request Data
Review of Requests
Independent Review Panel
Data Sharing Agreement
Access to Data
FAQs
Metrics
News
View List of Selected Studies
and choose next steps
Clear All
Home
About Us
Contact Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Sponsors/Funders
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
About
In order to add studies to your selected studies list, please Login or Create an Account if you don't have one yet.
*BI-1123.28
Study Sponsor:
Boehringer Ingelheim
Study Title
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
Medicine or Vaccine (generic name)
tenecteplase
Sponsor Identification Number
1123.28
Trial Registry Identification Number(#'s)
NCT00623623
Medical Condition
Myocardial Infarction
Phase
Phase 3
Link to study details on the BI Clinical Study Register
http://trials.boehringer-ingelheim.com/trial_results/clinical_trials_overview.html
Link to study details on ClinicalTrials.gov (if available)
https://clinicaltrials.gov/ct2/show/NCT00623623?term=1123.28&rank=1&submit_fld_opt=
Link to study details on EudraCT (if available)
Datasets and Documents Available for this Study
Raw dataset
Annotated case report form
Dataset specifications
Protocol with any amendments
Analysis-ready dataset
Reporting and analysis plan
Clinical study report
Additional information about the data and documents available for this study
Date Added to this Site
November 2015